http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5794873-B2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-5794873-B2
titleOfInvention Antitumor agent
priorityDate 2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6394114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426131764
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407940850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413267103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10003614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10454488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426100811
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122362100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422710143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422416304

Total number of triples: 30.